by The Kidney Transplant Market is estimated to be valued at US$ 5.8 billionin 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Kidney transplantation involves surgically placing a healthy kidney from a living or deceased donor into a patient with kidney failure. It is a treatment option for end-stage renal disease with benefits over long-term dialysis. The products in this market include pre-transplant immunomodulatory drugs, immunosuppressive drugs, tissue typing tray, and perfusion solutions that help maintain the functioning of donor kidneys outside the body.
Market Dynamics:
The growth of the kidney transplant market is driven by the rising cases of chronic kidney disease and end-stage renal disease. According to data, chronic kidney disease affects over 10% of the world’s population and is a major cause of death globally. Moreover, the increasing geriatric population also enhances the risk of developing kidney diseases due to age-related changes in renal functioning. This has boosted the demand for transplantation as a treatment option. Furthermore, technological advancements in immunosuppressive therapy regimens to reduce risks of transplant rejection also support the market growth. However, high costs associated with transplantation procedures and immunosuppressive drugs hinder the widespread adoption.
Segment Analysis:
Content: The global kidney transplant market can be segmented based on procedure type, source, and end user. Based on procedure type, the living donor transplant segment dominates the market. This is because living donor transplants have better outcomes than deceased donor transplants due to younger and healthier donor kidneys being used. Based on source, the type segments include living donors and deceased donors. The living donors segment dominates as transplants from living donors have better long-term survival rates than deceased donor transplants.
PEST Analysis:
Political: Governments are focusing on increasing funding for organ donation and transplantation programs to reduce transplantation waiting lists. Regulations impose strict guidelines on transplant procedures to ensure ethical practices and patient safety.
Economic: Rising healthcare expenditure and increasing cases of renal diseases are fueling market growth. However, the high costs associated with organ transplant procedures could hinder market expansion.
Social: Poor public awareness about organ donation and religious/cultural beliefs prevent people from donation, leading to organ shortages. Campaigns to encourage donation and overcome taboos can potentially increase organ availability.
Technological: Advancements in immunosuppressant drugs, organ preservation solutions, transplant surgical techniques, and diagnostics have improved post-transplant outcomes and patient survival rates. Developing xenotransplantation technologies also hold promise.
Key Takeaways:
The Global Kidney Transplant Market Growth is expected to witness high, exhibiting CAGR of 4.2% over the forecast period, due to increasing prevalence of renal diseases like diabetes, hypertension, and glomerulonephritis.
Regionally, North America dominates the global kidney transplant market owing to a large patient population, continually growing geriatric population, rising prevalence of ESRD, and strong healthcare infrastructure and reimbursement framework. Asia Pacific is anticipated to grow at the fastest rate due to improving access to transplant procedures and increasing healthcare spending.
Key players operating in the kidney transplant market are Sanofi, Pfizer, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic, Preservation Solution Inc., TransMedics, Inc., Organ Recovery Systems, and Transonic Systems Inc. Major players are focusing on developing innovative immunosuppressants and diagnostic technologies to gain a competitive edge in the market.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
